GFA
8783
Pluszero
5132
Pixel
2743
Metaplanet
3350
Chiome Bioscience
4583
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -61.89%88.23M | -24.98%231.47M | -10.73%308.53M | -7.65%345.62M | -22.79%374.23M | 7.54%484.68M | 5.96%450.7M | 12.28%425.36M | -3.62%378.85M | 57.26%393.08M |
Net profit before non-cash adjustment | -906.19%-759.38M | 33.86%94.19M | -39.84%70.37M | -23.21%116.96M | -50.69%152.32M | 7.35%308.89M | -0.61%287.74M | 14.20%289.52M | 44.95%253.52M | 21.22%174.89M |
Total adjustment of non-cash items | 338.63%794.24M | 1.91%181.08M | -17.95%177.69M | 6.10%216.57M | 12.13%204.11M | 20.58%182.03M | 3.76%150.96M | -1.34%145.49M | -35.03%147.47M | 53.19%226.99M |
-Depreciation and amortization | 40.32%287.09M | 16.79%204.6M | 3.59%175.18M | 0.49%169.11M | 9.95%168.29M | 10.39%153.05M | 9.25%138.65M | -6.20%126.91M | -4.61%135.3M | 4.90%141.84M |
-Reversal of impairment losses recognized in profit and loss | --483.16M | --0 | ---- | --2.4M | ---- | --979K | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -152.46%-5.25M | 395.25%10.02M |
-Disposal profit | --0 | ---1.15M | --0 | -96.50%1.4M | --39.83M | ---- | --86K | --0 | -92.63%59K | --801K |
-Remuneration paid in stock | ---- | ---- | ---- | ---- | -36.49%4.19M | 92.72%6.59M | --3.42M | --0 | ---- | ---- |
-Other non-cash items | 207.24%23.99M | -993.41%-22.37M | -94.27%2.5M | 633.32%43.67M | -138.25%-8.19M | 143.07%21.41M | -52.61%8.81M | 7.00%18.58M | -76.64%17.37M | 354.51%74.34M |
Changes in working capital | 221.83%53.36M | -172.43%-43.8M | 400.15%60.47M | -32.07%12.09M | 385.06%17.8M | -152.06%-6.24M | 224.36%11.99M | 56.43%-9.64M | -151.40%-22.13M | 79.28%-8.8M |
-Change in receivables | 110.11%27.13M | 58.88%12.91M | 132.43%8.13M | -540.06%-25.07M | -63.48%5.7M | -5.30%15.6M | 131.67%16.47M | -53.05%-52.01M | -844.36%-33.98M | 83.45%-3.6M |
-Change in inventory | -67.86%215K | 197.38%669K | -4,480.00%-687K | -100.98%-15K | 202.26%1.54M | -297.63%-1.5M | 194.65%760K | ---803K | ---- | ---- |
-Change in payables | 148.43%4.29M | -401.57%-8.86M | -83.27%2.94M | 60.91%17.56M | 279.06%10.91M | 39.63%-6.09M | -126.56%-10.1M | 220.91%38.01M | 327.53%11.85M | 74.93%-5.21M |
-Provision for loans, leases and other losses | 144.76%21.72M | -196.86%-48.52M | 155.40%50.09M | 5,785.22%19.61M | 97.58%-345K | -393.15%-14.24M | -5.69%4.86M | --5.15M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -53.12%-3.7M | -3.03%-2.42M | 36.41%-2.35M | 21.63%-3.69M | 7.60%-4.71M | -1.82%-5.09M | 6.19%-5M | -91.15%-5.33M | -36.97%-2.79M | -19.40%-2.04M |
Interest received (cash flow from operating activities) | -14.29%12K | -6.67%14K | 0.00%15K | 7.14%15K | 7.69%14K | 30.00%13K | -33.33%10K | -91.23%15K | 297.67%171K | -6.52%43K |
Tax refund paid | 130.99%19.64M | -619.15%-63.39M | 82.88%-8.81M | 46.40%-51.49M | -19.92%-96.06M | 5.46%-80.1M | 5.46%-84.73M | -5.90%-89.62M | -12.97%-84.63M | -66.24%-74.92M |
Other operating cash inflow (outflow) | 0 | 0.00%-1K | 0.00%-1K | -1K | 0 | 99.99%-1K | -12.53M | 0 | -1K | 0 |
Operating cash flow | -37.12%104.18M | -44.29%165.68M | 2.38%297.38M | 6.21%290.46M | -31.54%273.48M | 14.65%399.5M | 5.46%348.45M | 13.31%330.42M | -7.77%291.6M | 55.57%316.17M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 56.89%-25.65M | -148.30%-59.5M | 12.49%-23.96M | -34.47%-27.38M | -19.52%-20.36M | 61.79%-17.04M | -155.40%-44.59M | -133.22%-17.46M | 35.45%-7.49M | 86.09%-11.6M |
Net intangibles purchase and sale | -18.07%-335.04M | -124.10%-283.77M | -47.80%-126.63M | -53.84%-85.68M | -157.52%-55.69M | 47.29%-21.63M | 36.73%-41.03M | -55.04%-64.85M | 51.43%-41.83M | 36.77%-86.12M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | -56.16%-30M | -213.91%-19.21M | ---6.12M | ---- | ---- |
Net changes in other investments | 99.94%-1K | 93.04%-1.64M | -685.34%-23.57M | -300,000.00%-3M | ---1K | ---- | -107.74%-7.74M | 200.00%100M | -10,000,100.00%-100M | --1K |
Investing cash flow | -4.58%-360.69M | -98.04%-344.91M | -50.06%-174.16M | -52.59%-116.06M | -10.77%-76.06M | 39.00%-68.67M | -1,073.10%-112.57M | 107.75%11.57M | -52.81%-149.31M | 55.50%-97.71M |
Financing cash flow | ||||||||||
Net issuance payments of debt | --250M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | 6.05%-33.91M | 48.02%-36.1M |
Net common stock issuance | 100.74%320K | -148.87%-43.2M | 83.39%-17.36M | -32,752.50%-104.49M | -95.42%320K | -82.06%6.99M | 3,549.63%38.98M | -78.13%1.07M | -98.47%4.88M | --319.18M |
Increase or decrease of lease financing | 15.44%-69.52M | 5.26%-82.22M | 19.81%-86.78M | 3.45%-108.22M | -15.37%-112.08M | -44.32%-97.15M | -29.27%-67.32M | -57.31%-52.08M | -66.68%-33.1M | -165.19%-19.86M |
Net other fund-raising expenses | ---1K | ---- | 0.00%-1K | ---1K | ---- | ---- | ---- | ---- | 223.24%26.65M | ---21.62M |
Financing cash flow | 244.16%180.8M | -20.43%-125.42M | 51.04%-104.14M | -90.32%-212.71M | -23.96%-111.76M | -218.15%-90.16M | 44.44%-28.34M | -43.76%-51.01M | -114.69%-35.48M | 414.06%241.6M |
Net cash flow | ||||||||||
Beginning cash position | -19.55%1.25B | 1.24%1.56B | -2.34%1.54B | 5.75%1.58B | 19.25%1.49B | 19.91%1.25B | 38.72%1.04B | 16.57%751.48M | 249.19%644.67M | -33.57%184.62M |
Current changes in cash | 75.14%-75.72M | -1,696.16%-304.64M | 149.82%19.09M | -144.72%-38.31M | -64.41%85.66M | 15.97%240.68M | -28.68%207.54M | 172.44%290.98M | -76.78%106.81M | 593.21%460.05M |
Cash adjustments other than cash changes | 200.00%1K | ---1K | ---- | --1.48M | ---- | 0.00%-1K | ---1K | ---- | ---- | ---- |
End cash Position | -6.04%1.18B | -19.55%1.25B | 1.24%1.56B | -2.34%1.54B | 5.75%1.58B | 19.25%1.49B | 19.91%1.25B | 38.72%1.04B | 16.57%751.48M | 249.19%644.67M |
Free cash flow | -44.44%-256.51M | -220.98%-177.59M | -17.25%146.79M | -10.14%177.4M | -45.29%197.43M | 37.29%360.83M | 5.93%262.83M | 2.40%248.11M | 11.62%242.29M | 1,427.52%217.06M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |